Polygenic profiles define aspects of clinical heterogeneity in attention deficit hyperactivity disorder.
Sonja LaBiancaIsabell BrikellDorte HeleniusRobert LoughnanJoel MeffordClare E PalmerRebecca WalkerJesper R GådinMorten Dybdahl KrebsVivek AppaduraiMorteza VaezEsben AgerboMarianne Giørtz PedersenAnders Dupont BørglumDavid Michael HougaardOle MorsMerete NordentoftPreben Bo MortensenKenneth S KendlerTerry L JerniganDaniel H GeschwindAndrés IngasonAndrew W DahlNoah ZaitlenSøren DalsgaardThomas M WergeAndrew J SchorkPublished in: Nature genetics (2023)
Attention deficit hyperactivity disorder (ADHD) is a complex disorder that manifests variability in long-term outcomes and clinical presentations. The genetic contributions to such heterogeneity are not well understood. Here we show several genetic links to clinical heterogeneity in ADHD in a case-only study of 14,084 diagnosed individuals. First, we identify one genome-wide significant locus by comparing cases with ADHD and autism spectrum disorder (ASD) to cases with ADHD but not ASD. Second, we show that cases with ASD and ADHD, substance use disorder and ADHD, or first diagnosed with ADHD in adulthood have unique polygenic score (PGS) profiles that distinguish them from complementary case subgroups and controls. Finally, a PGS for an ASD diagnosis in ADHD cases predicted cognitive performance in an independent developmental cohort. Our approach uncovered evidence of genetic heterogeneity in ADHD, helping us to understand its etiology and providing a model for studies of other disorders.